227 related articles for article (PubMed ID: 35100877)
1. Citrobacter rodentium Infection Induces Persistent Molecular Changes and Interferon Gamma-Dependent Major Histocompatibility Complex Class II Expression in the Colonic Epithelium.
Mullineaux-Sanders C; Kozik Z; Sanchez-Garrido J; Hopkins EGD; Choudhary JS; Frankel G
mBio; 2021 Feb; 13(1):e0323321. PubMed ID: 35100877
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection.
Hopkins EGD; Roumeliotis TI; Mullineaux-Sanders C; Choudhary JS; Frankel G
mBio; 2019 Apr; 10(2):. PubMed ID: 30940698
[TBL] [Abstract][Full Text] [Related]
3. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma.
Simmons CP; Goncalves NS; Ghaem-Maghami M; Bajaj-Elliott M; Clare S; Neves B; Frankel G; Dougan G; MacDonald TT
J Immunol; 2002 Feb; 168(4):1804-12. PubMed ID: 11823513
[TBL] [Abstract][Full Text] [Related]
4. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection.
Shiomi H; Masuda A; Nishiumi S; Nishida M; Takagawa T; Shiomi Y; Kutsumi H; Blumberg RS; Azuma T; Yoshida M
Infect Immun; 2010 Jun; 78(6):2653-66. PubMed ID: 20351140
[TBL] [Abstract][Full Text] [Related]
5. The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium.
Dennis A; Kudo T; Kruidenier L; Girard F; Crepin VF; MacDonald TT; Frankel G; Wiles S
Infect Immun; 2008 Nov; 76(11):4978-88. PubMed ID: 18694964
[TBL] [Abstract][Full Text] [Related]
6. Constitutive induction of intestinal Tc17 cells in the absence of hematopoietic cell-specific MHC class II expression.
Rubino SJ; Geddes K; Magalhaes JG; Streutker C; Philpott DJ; Girardin SE
Eur J Immunol; 2013 Nov; 43(11):2896-906. PubMed ID: 23881368
[TBL] [Abstract][Full Text] [Related]
7. Citrobacter amalonaticus Inhibits the Growth of Citrobacter rodentium in the Gut Lumen.
Mullineaux-Sanders C; Carson D; Hopkins EGD; Glegola-Madejska I; Escobar-Zepeda A; Browne HP; Lawley TD; Frankel G
mBio; 2021 Oct; 12(5):e0241021. PubMed ID: 34609899
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.
Vallance BA; Deng W; Knodler LA; Finlay BB
Infect Immun; 2002 Apr; 70(4):2070-81. PubMed ID: 11895973
[TBL] [Abstract][Full Text] [Related]
9. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.
Bry L; Brigl M; Brenner MB
Infect Immun; 2006 Jan; 74(1):673-81. PubMed ID: 16369024
[TBL] [Abstract][Full Text] [Related]
10. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies.
Maaser C; Housley MP; Iimura M; Smith JR; Vallance BA; Finlay BB; Schreiber JR; Varki NM; Kagnoff MF; Eckmann L
Infect Immun; 2004 Jun; 72(6):3315-24. PubMed ID: 15155635
[TBL] [Abstract][Full Text] [Related]
11. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.
Chen CC; Louie S; McCormick B; Walker WA; Shi HN
Infect Immun; 2005 Sep; 73(9):5468-81. PubMed ID: 16113263
[TBL] [Abstract][Full Text] [Related]
12. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection.
Maiti AK; Sharba S; Navabi N; Lindén SK
PLoS One; 2018; 13(9):e0204567. PubMed ID: 30252907
[TBL] [Abstract][Full Text] [Related]
13. IL-22-dependent responses and their role during
Melchior K; Gerner RR; Hossain S; Nuccio S-P; Moreira CG; Raffatellu M
Infect Immun; 2024 May; 92(5):e0009924. PubMed ID: 38557196
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 produced by intestinal epithelial cells in response to Citrobacter rodentium infection plays a major role in innate immunity against this pathogen.
Zhang W; Du JY; Yu Q; Jin JO
Infect Immun; 2015 Aug; 83(8):3213-23. PubMed ID: 26034215
[TBL] [Abstract][Full Text] [Related]
15. Fcgamma receptor regulation of Citrobacter rodentium infection.
Masuda A; Yoshida M; Shiomi H; Ikezawa S; Takagawa T; Tanaka H; Chinzei R; Ishida T; Morita Y; Kutsumi H; Inokuchi H; Wang S; Kobayashi K; Mizuno S; Nakamura A; Takai T; Blumberg RS; Azuma T
Infect Immun; 2008 Apr; 76(4):1728-37. PubMed ID: 18227164
[TBL] [Abstract][Full Text] [Related]
16. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.
Simmons CP; Clare S; Ghaem-Maghami M; Uren TK; Rankin J; Huett A; Goldin R; Lewis DJ; MacDonald TT; Strugnell RA; Frankel G; Dougan G
Infect Immun; 2003 Sep; 71(9):5077-86. PubMed ID: 12933850
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of oral immunization with formalin-inactivated whole-cell Citrobacter rodentium on Citrobacter rodentium infection in mice.
Takahashi K; Hanamura Y; Tokunoh N; Kassai K; Matsunishi M; Watanabe S; Sugiyama T; Inoue N
J Microbiol Methods; 2019 Apr; 159():62-68. PubMed ID: 30817947
[TBL] [Abstract][Full Text] [Related]
18. The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses.
Berger CN; Crepin VF; Roumeliotis TI; Wright JC; Serafini N; Pevsner-Fischer M; Yu L; Elinav E; Di Santo JP; Choudhary JS; Frankel G
PLoS Pathog; 2018 Oct; 14(10):e1007406. PubMed ID: 30365535
[TBL] [Abstract][Full Text] [Related]
19. CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen.
Reid-Yu SA; Small CL; Coombes BK
Eur J Immunol; 2013 Oct; 43(10):2638-49. PubMed ID: 23775576
[TBL] [Abstract][Full Text] [Related]
20. Formyl peptide receptor 2 orchestrates mucosal protection against
Sharba S; Venkatakrishnan V; Padra M; Winther M; Gabl M; Sundqvist M; Wang J; Forsman H; Linden SK
Virulence; 2019 Dec; 10(1):610-624. PubMed ID: 31234710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
